- Home
- SCS vs NNNN Comparison
SCS vs NNNN Comparison
Compare SCS & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCS
- NNNN
- Stock Information
- Founded
- SCS 1912
- NNNN 2021
- Country
- SCS United States
- NNNN Germany
- Employees
- SCS N/A
- NNNN N/A
- Industry
- SCS Office Equipment/Supplies/Services
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SCS Consumer Discretionary
- NNNN Health Care
- Exchange
- SCS Nasdaq
- NNNN Nasdaq
- Market Cap
- SCS 1.8B
- NNNN 2.2B
- IPO Year
- SCS 1998
- NNNN 2025
- Fundamental
- Price
- SCS $16.88
- NNNN $42.30
- Analyst Decision
- SCS Buy
- NNNN
- Analyst Count
- SCS 1
- NNNN 0
- Target Price
- SCS $16.00
- NNNN N/A
- AVG Volume (30 Days)
- SCS 1.7M
- NNNN 57.1K
- Earning Date
- SCS 09-24-2025
- NNNN 01-01-0001
- Dividend Yield
- SCS 2.37%
- NNNN N/A
- EPS Growth
- SCS 37.12
- NNNN N/A
- EPS
- SCS 1.04
- NNNN 0.06
- Revenue
- SCS $3,217,700,000.00
- NNNN $8,185,146.00
- Revenue This Year
- SCS $4.30
- NNNN N/A
- Revenue Next Year
- SCS $3.51
- NNNN N/A
- P/E Ratio
- SCS $16.22
- NNNN $795.01
- Revenue Growth
- SCS 2.64
- NNNN 21.95
- 52 Week Low
- SCS $9.32
- NNNN $5.18
- 52 Week High
- SCS $17.25
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- SCS 66.29
- NNNN N/A
- Support Level
- SCS $16.68
- NNNN N/A
- Resistance Level
- SCS $17.02
- NNNN N/A
- Average True Range (ATR)
- SCS 0.25
- NNNN 0.00
- MACD
- SCS -0.18
- NNNN 0.00
- Stochastic Oscillator
- SCS 61.46
- NNNN 0.00
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.